Jeff Eiseman
Long only, deep value, special situations

PharmAthene Vs. SIGA: Rebutting G. Hudson's 'Potential Award' Article

G. Hudson just published an article about the outcome of the suit between PharmAthene (NYSEMKT:PIP) and SIGA Technologies (NASDAQ:SIGA). The context is that in 2011, Vice Chancellor Parsons ruled that SIGA had both violated the doctrine of promissory estoppel and breached its contractual obligation to negotiate in good faith. He imposed a remedy consisting of an income stream that was to be paid only when there were profits, and he based the form of his remedy upon his finding that SIGA had committed both acts.

In May 2013, the Supreme Court agreed that SIGA had breached its contractual obligation to negotiate in good faith, but found that the doctrine of promissory estoppel did not apply because...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details